Publications

Export 2723 results:
Sort by: Author Title Type [ Year  (Desc)]
2021
El-Aleam, R. A. H., R. F. George, H. H. Georgey, and H. M. Abdel-Rahman, "Bacterial virulence factors: a target for heterocyclic compounds to combat bacterial resistance", RSC Advances, vol. 11, pp. 36459–36482, 2021.
El-Aleam, R. A. H., R. F. George, H. H. Georgey, and H. M. Abdel-Rahman, "Bacterial virulence factors: a target for heterocyclic compounds to combat bacterial resistance", RSC Adv., vol. 11, pp. 36459, 2021. RSC Adv._2021.pdf
Krupovic, M., D. Turner, V. Morozova, M. Dyall-Smith, H. M. Oksanen, R. Edwards, B. E. Dutilh, S. M. Lehman, A. Reyes, D. P. Baquero, et al., "Bacterial Viruses Subcommittee and Archaeal Viruses Subcommittee of the ICTV: update of taxonomy changes in 2021", Archives of Virology, vol. 166, no. 11: Springer Vienna, pp. 3239–3244, 2021. Abstract
n/a
Elgohary, I., A. E. Eissa, N. G. Fadel, J. I. A. Elatief, and M. A. Mahmoud, "Bacteriological, molecular, and pathological studies on the Gram-positive bacteria Aerococcus viridans and Enterococcus faecalis and their effects on Oreochromis niloticus in Egyptian fish farms", Aquaculture Research, vol. 52, issue 5, pp. 2220-2232, 2021.
Mostafa, H. S., "Banana plant as a source of valuable antimicrobial compounds and its current applications in the food sector", Journal of Food Science, vol. 86, pp. 3778–3797, 2021.
Mohamed, S. M., E. A. Abdel-Rahim, T. A. A. Aly, A. M. M. naguib, and M. S. Khattab, Barley microgreen incorporation in diet-controlled diabetes and counteracted aflatoxicosis in rats, , 2021.
Stuart, D., M. Sandström, H. M. Youssef, S. Zakhrabekova, P. E. Jensen, D. Bollivar, and M. Hansson, "Barley Viridis-k links an evolutionarily conserved C-type ferredoxin to chlorophyll biosynthesis", The Plant Cell, 2021.
Ameera, M. A., M. I. Kamel, and S. A. Ali, "Barometric and spatiotemporal gait differences between leading and non-leading feet of handball players", Journal of the American Podiatric Medical Association , 2021. barometric_paper.pdf
Sarhan, M. D., M. Mostafa, I. Anwar, and H. Osama, "Barriers to completing therapy for Hepatitis C with direct acting-antivirals: A real-life experience from single Treatment Center in Egypt.", Journal of Primary Care & Community Health, vol. 12, pp. 1-6, 2021.
Said, K. A., S. F. Hegazy, and S. S. A. Obayya, "Basis expansion model for tracking and equalizing rapidly varying multimode fiber channels", Optical Fiber Technology, vol. 67, pp. 102695, 2021. alhamdul_allah_karim_oft_2021.pdf
Bantan, R., A. S. Hassan, E. Almetwally, M. Elgarhy, F. A. R. R. U. K. H. JAMAL, C. H. R. I. S. T. O. P. H. E. CHESNEAU, and M. ELSEHETRY, Bayesian Analysis in Partially Accelerated Life Tests for Weighted Lomax Distribution, , 2021.
Almarashi, A. M., A. Ali, A. S. Hassan, A. N. Zaky, and M. Elgarhy, "Bayesian Analysis of Dynamic Cumulative Residual Entropy for Lindley Distribution", entropy, 2021. 2021_bayesian_analysis_of_dcre_lindley.pdf
Hassan, A. S., S. M. Assar, and A. M. A. Elghaffar, "Bayesian Estimation of Power Transmuted Inverse Rayleigh Distribution", Thailand Statistician, vol. 19, issue 2, pp. 393-410, 2021. 2021_bayesian_estimation_of_power_transmuted_inverse_rayleigh.pdf
Hassan, A. S., S. M. Assar, and A. M. A. Elghaffar, "Bayesian Estimation of Power Transmuted Inverse Rayleigh Distribution", Thailand Statistician, vol. 19, issue 2, pp. 393-410, 2021. 9_2021_bayesian_estimation_power_transmuated_inverse_rayleigh.pdf
Hassan, A. S., S. M. Assaق, and A. M. A. Elghaffar, "Bayesian Estimation of Power Transmuted Inverse Rayleigh Distribution", Thailand Statistician, vol. 19, issue 2, pp. 393-410, 2021. 8_2021_bayesian_estimation_power_transmuated_inverse_rayleigh.pdf
Hassan, A. S., S. M. Assar, and M. A. Elghaffar, "Bayesian Estimation of Power Transmuted Inverse Rayleigh Distribution", Thailand Statistician, vol. 19, issue 2, pp. 393-410, 2021. 8_2021_bayesian_estimation_power_transmuated_inverse_rayleigh.pdf
Mansour, G. H., M. A. El-Magd, D. H. Mahfouz, I. A. Abdelhamid, M. F. Mohamed, N. S. Ibrahim, A. H. A. A. Wahab, and E. M. Elzayat, "Bee venom and its active component Melittin synergistically potentiate the anticancer effect of Sorafenib against HepG2 cells", Bioorganic Chemistry, vol. 116, 2021.
Mansour, G. H., M. A. El-Magd, D. H. Mahfouz, I. A. Abdelhamid, M. F. Mohamed, N. S. Ibrahim, A. H. A. A. Wahab, and E. M. Elzayat, "Bee venom and its active component Melittin synergistically potentiate the anticancer effect of Sorafenib against HepG2 cells", Bioorganic Chemistry, vol. 116: Elsevier, pp. 105329, 2021. Abstract
n/a
Mansour, G. H., M. A. El-Magd, D. H. Mahfouz, I. A. Abdelhamid, M. F. Mohamed, N. S. Ibrahim, A. H. A. A. Wahab, and E. M. Elzayat, "Bee venom and its active component Melittin synergistically potentiate the anticancer effect of Sorafenib against HepG2 cells", Bioorganic Chemistry, vol. 116: Academic Press, pp. 105329, 2021. Abstract
n/a
Mansour, G. H., M. A. El-Magd, D. H. Mahfouz, I. A. Abdelhamid, M. F. Mohamed, N. S. Ibrahim, A. H. A. A. Wahab, and E. M. Elzayat, "Bee venom and its active component Melittin synergistically potentiate the anticancer effect of Sorafenib against HepG2 cells", Bioorganic Chemistry, vol. 116: Academic Press, pp. 105329, 2021. Abstract
n/a
Batran, T. Z., M. K. Ismail, and A. A. A. Hassan, "Behavior of novel hybrid lightweight concrete composites under drop-weight impact loading", Structures, vol. 34, pp. 2789-2800, 2021.
Abu-Hamd, M., and N. M.Tawfik, "Behavior of screw connections in sheathed cold-formed steel walls", Journal of Constructional Steel Research, vol. 187, 2021.
Elfishawi, M., G. Mossallam, D. G. Augusto, G. Montero-Martin, H. de Bruin, L. Van de Pasch, P. J. Norman, E. Rozemuller, M. Fernandez-Vina, A. Abrudescu, et al., "Behçet disease, new insights in disease associations and manifestations: a next-generation sequencing study.", Clinical and experimental immunology, 2021. Abstract

Behçet disease is a multi-system disease associated with human leukocyte antigen (HLA) class I polymorphism. High-resolution next-generation sequencing (NGS) with haplotype analysis has not been performed previously for this disease. Sixty Egyptian patients diagnosed according to the International Study Group (ISG) criteria for Behçet disease and 160 healthy geographic and ethnic-matched controls were genotyped for HLA class I loci (HLA-A, B, C). For HLA class II loci (DRB1, DRB3/4/5, DQA1, DQB1, DPA1, DPB1), 40 control samples were genotyped. High-resolution HLA genotyping was performed using NGS and the results were analyzed. Clinical manifestations were oral ulcers (100%), genital ulcers (100%), eye (55%) and neurological (28%) and vascular involvement (35%). HLA-B*51:08 [odds ratio (OR) = 19·75, 95% confidence interval (CI) = 6·5-79; P < 0·0001], HLA-B*15:03 (OR = 12·15, 95% CI = 3·7-50·7; P < 0·0001), HLA-C*16:02 (OR = 6·53, 95% CI = 3-14; P < 0·0001), HLA-A*68:02 (OR = 3·14, 95% CI = 1·1-8·9; P < 0·01) were found to be associated with Behçet disease, as were HLA-DRB1*13:01 and HLA-DQB1*06:03 (OR = 3·39, 95% CI = 0·9-18·9; P = 0·04 for both). By contrast, HLA-A*03:01 (OR = 0·13, 95% CI = 0-0·8; P = 0·01) and HLA-DPB1*17:01 were found to be protective (OR = 0·27, 95% CI = 0·06-1·03; P = 0·02). We identified strong linkage disequilibrium between HLA-B*51:08 and C*16:02 and A*02:01 in a haplotype associated with Behçet disease. HLA-B*51:08 was significantly associated with legal blindness (OR = 2·98, 95% CI = 1·06-8·3; P = 0·01). In Egyptian Behçet patients, HLA-B*51:08 is the most common susceptibility allele and holds poor prognosis for eye involvement.

Tourism